NCT07896486
Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Start date changed from estimate of Sep 2026 to Nov 4, 2026
- Site details revised
- Minor Study title shortened, about 16 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Change from baseline in PIH of the face at Week 12, as assessed by the Post-Acne Hyperpigmentation Index (PAHPI) score
Timeframe: Baseline; 12 weeks
Secondary (2)
Number or participants who tolerated the investigational product as assessed by the investigator
Patient-reported stigmatization, as measured by the PUSH-D questionnaire at week 12
Arms and interventions
Participants with Acne-Associated Post-Inflammatory Hyperpigmentation using the Vinoperfect SerumOther
Participants will undergo a standardized twice-daily skincare regimen for 12 weeks. In the morning, participants will cleanse their face, apply the Vinoperfect Brightening Serum, apply moisturizer, and then apply SPF 50+ sunscreen. In the evening, participants will cleanse their face, apply the Vinoperfect Brightening Serum, and apply moisturizer.
Other: Vinoperfect brightening serum
Sites
1 site in 1 country
- Weill Cornell Medicine DermatologyNew York, New York, United States